sno is a member of the ski oncogene family and shares ski's ability to transform avian ®broblasts and induce muscle dierentiation. Ski and Sno are nuclear proteins that form homodimers and heterodimers. Ski activates transcription of cellular and viral enhancers and we have identi®ed a DNA binding site (GTCTAGAC) through which it represses transcription. In this work, we show that SnoN binds this site and represses transcription of reporters with this binding site as an upstream element. Using fusions with the Gal4-DNA binding domain in a heterologous reporter assay, we identify a tripartite repression domain in SnoN. A 107 amino acid stretch of the SnoN repression domain, that contains two of the subdomains, is closely related to the minimal region of Ski required for transformation. The third subdomain is unique to SnoN. By analysing deletions involving each of the subdomains, we show that subdomains II and III are also required for DNA binding and cellular transformation. We provide evidence for a quenching mechanism of transcriptional repression by which subdomain II binds to TAF II 110.
Introduction
The ski oncogene family has two members, ski and sno. Both Ski and SnoN are nuclear proteins that are capable of transforming avian ®broblasts and inducing muscle dierentiation. A sno cDNA was ®rst isolated by screening human cDNA libraries with a chicken ski probe (Nomura et al., 1989) and has subsequently been cloned from chicken (Boyer et al., 1993) and mouse (Pelzer et al., 1996) cDNA libraries and from a chicken genomic library (Givol et al., 1995) . The chicken sno gene is about 12 kb long and contains six exons, the ®rst of which is noncoding (Givol et al., 1995) . In mammals sno is alternatively spliced to yield several isoforms but chickens appear to express only the largest form of the protein, SnoN. Chicken SnoN is a 76 kDa protein that is localized in the nucleus (Boyer et al., 1993) . Its forced expression at high levels induces clonal growth of chicken embryo ®broblasts (CEF) in soft agar and induces muscle dierentiation in quail embryo ®broblasts (QEF) (Boyer et al., 1993) . Both of these eects were shown to be dosage dependent. Endogenous sno is expressed at low levels in most cell lines and tissues (Pelzer et al., 1996) and shows tissue and stage-speci®c¯uctuations in expression during mouse development (Lyons, 1994; Pelzer et al., 1996) . In addition, induction of sno mRNA expression has been observed following serum stimulation of fibroblasts (Pearson-White and Crittenden, 1997) and after serum removal from myoblasts prior to terminal muscle dierentiation (Mimura et al., 1996) .
Chicken SnoN shares the transforming and myogenic activities of Ski and their sequences are closely related in the region identi®ed as the essential transforming domain of Ski (Zheng et al., 1997) . However, aside from its nuclear location and its ability to dimerize with Ski, little is known of the molecular mechanisms of SnoN action. We have previously identi®ed the GTCT element (GTCTA-GAC) as a speci®c DNA binding site for c-Ski (Nicol and Stavnezer, 1998) . We showed that c-Ski acts as a potent repressor of transcription using a reporter with upstream GTCT elements. The present studies were initiated to determine whether chicken SnoN possesses these activities and, if so, whether the domain responsible for these activities is required for cellular transformation.
Results

SnoN binds the GTCT element and represses transcription
To determine whether SnoN binds the GTCT element, we have performed electrophoretic mobility shift assays (EMSAs). We observe an enhanced mobility shift using nuclear extracts of CEFs infected with a retrovirus expressing epitope tagged SnoN compared to that observed with extracts of uninfected CEFs (compare Figure 1A , lanes 1 and 7). The Sno-CEF extract produces a broad complex that is not super-shifted by two dierent anti-Ski mAbs (lanes 2 and 3) but is disrupted and super-shifted by an anti-Sno mAb (lane 4) and super-shifted (lane 5) by the epitope tag monoclonal antibody (EE-mAb) . The endogenous complex is partially super-shifted by both anti-Ski and anti-SnoN mAbs indicating that many of these complexes contain both proteins. In order to further demonstrate the speci®city of the SnoN complexes observed, a second EMSA was performed. Figure 1B shows that EE tagged SnoN forms a complex with the tandem repeat of the GTCT element (lane 1) that is super-shifted with the EE antibody (lane 2). Binding to this probe is competed by unlabeled GTCT (lane 3) but not by an unlabeled mutated competitor (lane 4).
Having found that SnoN binds the GTCT element, we tested its ability to regulate transcription from a reporter with upstream copies of the GTCT element (GTCT/2x2tkCAT). As shown in Figure 2 , SnoN represses transcription of this reporter in a dosedependent fashion, reducing expression by a factor of ®ve at 400 ng of the SnoN expression plasmid. Repression by SnoN requires its binding to the GTCT element since no repression is observed with the reporter lacking this sequence (MutGC).
Mapping the SnoN repression domain
We next sought to determine whether SnoN has an identi®able repression domain and, if so, to map this domain in the protein. In order to analyse this putative domain independently from its DNA binding domain, we constructed fusions containing dierent segments of SnoN protein attached to the DNA binding domain (DBD) of the yeast transcriptional activator, Gal4 (amino acids 1 ± 147) (Giniger et al., 1985) . We then performed transient reporter gene assays by cotransfecting these fusions with a reporter that contains ®ve copies of the Gal4 binding site upstream of the HSV-1 thymidine kinase (tk) promoter (GL3.2-tk-Luc). The tk promoter provides reasonably high constitutive expression, facilitating the detection of transcriptional repression (Luckow and Schutz, 1987) .
We ®rst tested a Gal-SnoN fusion protein that contains the entire 690 amino acids of SnoN and found that it represses the Gal reporter, reducing expression to 11% of the control (Figure 3 ). This result demonstrates that SnoN possesses a repression domain that functions independently of its DBD. To map the repression domain, we next assayed the activity of a nested set of deletions from the carboxyl-terminal end of SnoN (Figure 3) . The results show that SnoN(1 ± 432), in which the C-terminal 258 residues are deleted, including the entire dimerization domain, produces as potent repression as full-length SnoN (Figure 3) . A construct consisting of the carboxyl-terminal 399 amino acids of SnoN(299 ± 690) and containing the dimerization domain (residues 506 ± 690) (Heyman and Stavnezer, 1994) does not repress transcription (data not shown). The most potent repression is observed with SnoN(1 ± 291) and SnoN(1 ± 254), both of which reduce reporter expression to 2% of the control value. Further deletion results in a decrease in repression activity indicating that the C-terminal boundary of the repression domain is between residues 254 and 291.
Analysis of progressive C-terminal deletions from residue 254 indicates that the repression domain consists of three functional subdomains. Deletions to residues 234 and 213, reduce repression activity by a factor of three compared to that observed with SnoN(1 ± 254) suggesting that the segment between residues 213 and 254 includes one of the functional subdomains (subdomain III). Deletions from residue 213 to residues 172 and 84 result in attenuation of repression activity by another factor of three, suggesting the presence of a second subdomain within this region (subdomain II). An additional deletion to residue 37 completely abolishes repression activity Figure 1 Binding by SnoN to the GTCT element. EMSAs were performed as described in Materials and methods with nuclear extracts from the indicated CEFs and a 32 P-labeled oligonucleotide probe containing two tandem copies of the GTCTAGAC binding site (GTCT/2). (a) Antibody supershifts were performed with anity puri®ed monoclonal antibodies (mAbs); G8 and M6 are speci®c for dierent epitopes of c-Ski, EE is speci®c for the Glu-Glu epitope tag on SnoN, 3E6 is speci®c for SnoN. (b) EMSAs with a CEF SnoN extract alone (lane 1) and with the addition of the EE antibody (lane 2). The shifted complex is competed with 100-fold excess of cold GTCT/2 (lane 3), but not with a cold competitor containing two tandem copies of a mutated binding site (mutGC) of sequence CTGTACAG (lane 4) Figure 2 SnoN represses transcription via the GTCT element. DF1 cells were co-transfected with GTCT/262tkCAT or mutGC/ 2tkCAT (a reporter with a tandem mutated binding site CTGTACAG) and the indicated quantities of the RSVPL expression plasmid encoding SnoN. At 36 ± 48 h post transfection cells were harvested, lysed and the activity of CAT determined as described in Materials and methods. Relative repression is calculated by setting the level of CAT activity obtained with the empty RSVPL plasmid to one placing a third subdomain in the segment from residue 1 to residue 84. A Gal-SnoN fusion containing only residues 38 ± 84 has repression activity close to that of the entire 1 ± 84 segment, indicating that subdomain I is largely contained in this smaller segment.
Amino terminal and internal deletions within the 1 ± 291 region provide further evidence for the presence of three functional subdomains. An amino terminal deletion to residue 148 in SnoN (148 ± 291) reduces the repression activity slightly, but it is restored completely to that of SnoN (1 ± 291) by addition of subdomain I in SnoN (1 ± 84; 148 ± 291). This result indicates that residues 85 ± 147 are dispensable for repression activity and that subdomains II and III are C-terminal to residue 148. In fact, we ®nd that any deletion involving residues 148 ± 213 results in a reduction in repression (compare 1 ± 172; 213 ± 291 and 1 ± 84; 172 ± 291 to 1 ± 291, or 172 ± 291 to 148 ± 291), apparently by removing part of subdomain II while leaving subdomain III intact. Similarly, deletions involving residues 213 ± 291 also reduce repression activity, apparently by disrupting subdomain III (compare 148 ± 234 to 148 ± 254 or 1 ± 213 to 1 ± 291). Subdomain II and III, have little repression activity on their own (148 ± 234 and 172 ± 291). However, either of these domains augments the repression activity of subdomain I (compare 1 ± 213 to 1 ± 84 and 1 ± 84; 172 ± 291 to 1 ± 84). This establishes that subdomains II and III can act independently of each other when supplemented with subdomain I. In summary, the results identify a tripartite repression domain in SnoN consisting of subdomain I (residues 38 ± 84), and a separate stretch of 107 amino acids that contains subdomain II (residues 148 ± 213) and subdomain III (residues 213 ± 254).
To determine whether any of the results in Figure 3 could be ascribed to dierences in protein abundance or to the expression of inappropriate polypeptides, Western analysis of parallel transfections were performed. The results show that the proteins are of the correct size and that the fusion proteins with the greatest repression activity are expressed at the lowest levels (data not shown). Therefore, the dierences in repression are not the result of dierences in the level of protein expression.
The SnoN repression domain is required for transformation
It was previously shown that infection by a retroviral vector which expresses SnoN causes transformation of CEFs as measured by clonal growth in soft agar (Boyer et al., 1993) . To establish a linkage between this biological activity and transcriptional repression, we next sought to determine whether the transforming ability of SnoN is dependent on the repression domain. Since the SnoN constructs used in the molecular experiments contain the EE epitope tag, we ®rst had Figure 3 Mapping the SnoN repression domain. The segments of SnoN indicated were fused in frame at the C-terminal end of the Gal4DBD (residues 1 ± 147) in the SG424 expression plasmid. These plasmids (100 ng) were co-transfected with the pGL3.2tk-Luc (600 ng) luciferase reporter plasmid into DF1 cells and assayed for luciferase activity at 36 ± 48 h post transfection as described in Materials and methods. The data are expressed as percent activity, which equals the ratio of the activity detected with the indicated SnoN fusions divided by that detected with vector only. Data shown are the averages of six replicates except * is the average of two values to determine whether this form of SnoN is biologically active. As shown in Figure 4 , full-length EE tagged SnoN transforms CEFs (2.8% growth in soft agar) as eciently as previously reported for the non-tagged protein (Boyer et al., 1993) . We then compared induction of growth in soft agar by EE tagged fulllength SnoN and four dierent deleted forms of SnoN that are missing portions of the repression domain. Equal numbers of cells were suspended in 0.35% agar (see Materials and methods) and their ability to produce colonies was determined after 30 days of culture. In contrast to the full-length protein, the three forms of SnoN with deletions in subdomains II or III are completely transformation defective. Deletion of subdomain I in SnoND1 ± 146 does not abolish SnoN's transforming potential (1.7% growth in soft agar), although it is attenuated relative to that of the fulllength protein.
The infected cells used in these assays were analysed by Western blotting for SnoN protein size and expression level ( Figure 5 ). The results show that all SnoN forms are of the predicted size. Both of the forms with subdomains II and III intact (full-length SnoN (lanes 4 and 5) and the SnoND1 ± 146 (lane 6)) are expressed at 5 ± 10 times lower levels than the three transformation-defective constructs which contained deletions of these domains (lanes 1 ± 3). Thus the failure of the latter three to induce transformation is not due to low levels of protein expression.
The SnoN repression domain overlaps its DNA binding domain
We next wanted to determine whether the transformation activity of SnoN also correlates with its ability to bind the GTCT element. Nuclear extracts, prepared from cultures of the same stocks of infected CEFs used in the soft agar cloning assay, were next used to perform EMSAs ( Figure 6 ). As seen previously, ( Figure 1B ), EE tagged SnoN forms a complex with the tandem repeat of the GTCT element ( Figure 6 , lane 1) that is super-shifted with the EE antibody (lane 2). None of the extracts from CEFs expressing SnoN forms with deletions within subdomains II or III produced a complex with GTCT that is super-shifted by the EE mAb ( Figure 6A , lanes 3 ± 8). The extract of CEFs expressing SnoND1 ± 146 produces a smaller (7) and with added EEmAb (+) of SnoN and four SnoN deletion constructs. The autoradiograph shown here was exposed ®ve times longer than the one in Figure 1b. (b) EMSAs were performed with a single GTCT site and extracts of infected cells expressing SnoND1 ± 146 in the absence of antibody (7) or in the presence of EE mAb and Ski-speci®c M6 mAb, as indicated complex, consistent with the size of this protein, and this complex is shifted by EE mAb ( Figure 6A , lanes 9 and 10). The quantity of this complex is signi®cantly less than that produced by full-length SnoN, requiring the gel to be exposed to X-ray ®lm ®ve times longer in Figure 6A than in Figure 1B . Thus the inability of the transformation-defective deletion mutants of SnoN to bind the GTCT element and the partial binding activity by the SnoND1 ± 146 mutant indicates that, among the forms tested, speci®c DNA binding by SnoN correlates with its ability to transform CEFs.
Because SnoND1-146 was the only form that was able to bind the GTCT site ( Figure 6A ), we sought to clarify the DNA binding results by performing a second EMSA. In this case, the probe used contained only a single GTCTAGAC site, and complexes were tested for super-shifting with both the EE mAb and a c-Ski speci®c mAb, M6. It has been established that Ski and Sno form homodimers and heterodimers with each other (Heyman and Stavnezer, 1994; unpublished data) . Use of the single-copy binding site probe allows the sifted complexes to be unambiguously evaluated for the presence of either c-Ski homodimers, SnoN homodimers or Ski : SnoN heterodimers. Again the SnoND1 ± 146 extract forms a complex that is supershifted with the EE mAb ( Figure 6B, lanes 1 and 2) . This complex shows no apparent super-shift with M6 anti-Ski ( Figure 6B , lane 3) indicating that the complex is formed by a SnoND1 ± 146 homodimer. Thus DNA binding, even at the low level exhibited by SnoND1 ± 146, appears to be required for transformation by virally expressed SnoN proteins.
The mechanism of repression by SnoN
The reporter used in all of our transient expression experiments employed the tk promoter. This promoter includes 105 base pairs of upstream sequence including a site responsive to the transcriptional activator, Sp1 (Galvin and Shi, 1997; McKnight et al., 1981) . Because some repressors function by quenching the activity of activators, we tested whether SnoN repression of this promoter might involve quenching of Sp1 activation. Sp1 activation is apparently mediated by its interaction with the TF II D polypeptide, TAF II 110, so we examined the interaction of SnoN with this factor. To accomplish this, 35 S-labeled TAF II 110 and TAF II 60 (as a speci®city control) were generated by in vitro transcription/ translation and tested for binding to glutathione Stransferase (GST) -SnoN. The labeled proteins were mixed with glutathione agarose containing immobilized GST-SnoN or GST, washed, and the bound proteins were analysed by SDS ± PAGE. As shown in Figure  7A , binding of TAF II 60 to GST-SnoN is only slightly greater than to GST alone (lanes 1 ± 3) and the same was found to be true for TAF II 80 (data not shown). On the other hand, TAF II 110 binds GST-SnoN very eciently; about 20% of the labeled protein binds to GST-SnoN whereas less than 1% binds to GST alone ( Figure 7A , lanes 4 ± 6).
Previous work had shown that the amino terminal half of TAF II 110 contained the domain responsible for binding SP1 (Hoey et al., 1993) . We have therefore performed binding assays with a segment of TAF II 110 (residues 1 ± 457) that contains this domain and ®nd that it also binds GST-SnoN ( Figure 7B, lanes 1 ± 3) . In the reciprocal binding experiment, we ®nd that GST-TAF II 110(1 ± 457) binds 35 S-labeled, in vitro translated SnoN ( Figure 7B , lanes 4 ± 6). These results show that residues 1 ± 457 of TAF II 110, that include the Sp1 binding domain, are sucient for its interaction with SnoN.
We next tested a series of SnoN deletion constructs to determine whether the region in SnoN that mediates interaction with TAF II 110 overlaps the repression domain. These proteins were labeled by in vitro transcription/translation and tested for binding to immobilized GST-TAF II 110(1 ± 457). As indicated in Figure 8 , deletion of the amino terminal 148 residues of SnoN (subdomain I) does not eect its binding by GST-TAF II 110. However, the three deletions within the region from residue 102 to 323 that involve subdomains II and III result in little or no binding. This places the TAF II 110 binding site between residues 148 and 323.
Surprisingly, SnoN(1 ± 291), which contains the entire repression domain, binds GST-TAF II 110 quite poorly ( Figure 7C, lanes 10 ± 12, Figure 7) . We reasoned that this might be due to the absence of an ecient dimerization domain in this protein. We tested this hypothesis by fusing segments of SnoN to an extraneous dimerization domain and assaying their ability to bind GST-TAF II 110. We selected the dimerization domain within the Gal4 DBD(1 ± 147) because the repression domain mapping experiments showed that fusion products of Gal4(1 ± 147) and SnoN are functional proteins. This region of Gal4 is widely used as a DBD in heterologous reporter assays, but it is 3) , Gal-SnoN 1 ± 291 (lanes 4 ± 6), Gal-SnoN 1 ± 213 (lanes 7 ± 9), or SnoN 1 ± 291 (lanes 10 ± 12) also a known dimerization domain (Carey et al., 1989) . As can be seen in Figure 7C , addition of the Gal4 dimerization domain to SnoN(1 ± 291) increases its binding to GST-TAF II 110 by tenfold (compare lanes 4 ± 6 to lanes 10 ± 12). A similar level of binding is observed with Gal-SnoN(1 ± 213), but when the SnoN is truncated to include only residues 1 ± 84, no TAF II 110 interaction is seen (lane 1 ± 3 ). This latter result shows that the binding by the larger SnoN fusions is not occurring through the Gal4 domain and that the segment required for binding is between residues 84 and 213. Additional binding studies were performed to re®ne the binding domain as shown in Figure 8 . The results indicate that the minimal segment of SnoN required for interaction with TAF II 110 includes residues 148 ± 213. This region constitutes subdomain II.
The data on TAF II 110 interaction suggests that SnoN represses the tk promoter in part by quenching Sp1 activation. However, its possession of a tripartite repression domain suggests that SnoN may repress transcription by a mechanism that does not involve quenching and might therefore be independent of promoter context. To test this possibility we performed transient expressions assays with a reporter driven by an adenovirus E1B TATA box promoter (Lillie and Green, 1989) with ®ve upstream Gal4 binding sites. As shown in Figure 9 , Gal4 fusion proteins with either full-length SnoN or SnoN(1-291) reduce expression of this promoter to 1% of the control value. In contrast, a fusion of Gal4 with the acidic activator, VP16, gives more than 100-fold activation of the reporter. These results show that SnoN is able to repress transcription independently of both Sp1 and speci®c promoter context.
Discussion
The ski-related gene sno has the ability to transform CEFs and to both transform and induce muscle dierentiation in QEFs (Boyer et al., 1993) . Although the SnoN protein does not bind DNA independently, by using nuclear extracts from CEFs we were able to show that it participates in binding a speci®c DNA binding site (GTCTAGAC), originally identi®ed for Ski-containing protein complexes (Nicol and Stavnezer, 1998) . The present work demonstrates that SnoN represses transcription of a reporter with this site as part of an upstream regulatory element. The fact that Sno and Ski are transcriptional repressors with the same DNA binding speci®city, suggests that these activities are related to their shared transforming and myogenic activities.
We have shown that repression by SnoN does not require its DNA binding activity by fusing it to the DNA binding domain (amino acids 1 ± 147) of the yeast transcriptional activator Gal4 (Giniger et al., 1985) . Reporter assays demonstrate that this fusion possesses repression activity that is dependent on the presence of a Gal4 binding site in the reporter. Moreover, SnoN expressed without the fused Gal4 DBD fails to repress transcription of the Gal binding site reporter, indicating that repression is not due to a squelching mechanism. These results show SnoN is an active repressor and have allowed us to map the repression domain to residues 1 ± 291.
The domain can be further dissected into three subdomains. Subdomains II and III form a contiguous domain that includes residues 148 ± 254. The amino acid sequence of the 148-254 segment of SnoN is very closely related to a segment of c-Ski (amino acids . When aligned, these two domains show 73% identity and 77% similarity. The ®rst 90 residues of these homologous regions are 84% identical and 90% similar. This high degree of relatedness to the repression domain of SnoN suggests that the previously described repression activity of Ski will map to this domain as well. In fact, results of subsequent studies with Ski indicate that this is the case (unpublished results).
The third subdomain is contained within residues 1 ± 84. This segment is amino terminal to the region of Slabeled SnoN segments were determined as described in the legend to Figure 7 . (7), less than 1%; (+/7), approximately 1 ± 5%; (+), greater than 5% of the target protein bound. DBD is the Gal4 DBD fused in frame to the amino termini of the indicated segments of SnoN Figure 9 Eect of Gal4-SnoN fusions on a minimal promoter. The activities of the indicated segments of SnoN or VP16 fused to the DNA binding domain (DBD) of Gal4 were assayed as described in the legend to Figure 3 . The reporter, G5BLuc-Basic, contains ®ve Gal4 binding sites upstream of the E1B TATA box. Activity is relative to that with RSVPL alone. Data shown are the averages of two replicates SnoN that is related to Ski and so represents an element unique to the SnoN protein. Expressed as a Gal4-DBD fusion, this region represses transcription by a factor of four and it increases the level of repression of subdomain II and subdomain III by a similar factor. The additive eect of subdomain I suggests that it represses transcription independently and by a dierent mechanism from that of the other repression domains (residues 148 ± 291). Although many repressors operate through single, relatively small repression domains, there are others that possess large repression elements consisting of multiple repression subdomains that function by dierent mechanisms (Hanna-Rose and Hansen, 1996) . For example, the repression domain of the thyroid hormone receptor appears to contain three subregions (Baniahmad et al., 1992) that repress transcription through interactions with the TATA box binding protein (TBP) (Baniahmad et al., 1993; Fondell et al., 1996) , SMRT (Horlein et al., 1995) and a third, unidenti®ed factor.
In the present studies, we have determined that two of the repression subdomains of SnoN coincide with the region responsible for transformation. Using a series of deletions across the repression domain, we show that subdomains II and III are required for cellular transformation. The defect in transformation observed with mutants bearing deletions of the repression domain is not due to decreased levels of expression because these forms are expressed at higher levels than either full length SnoN or SnoN(D1 ± 146). Deletion of subdomain I in SnoND1 ± 146 does not abolish SnoN's transforming activity, although this activity is reduced by about twofold. Thus, subdomain I is not required for transformation but appears to contribute to the potency SnoN in inducing the fully transformed phenotype.
Transcriptional repression frequently requires that the factor mediating the eect bind to DNA, or to another factor already bound to DNA. In many instances, the protein/DNA interaction is accomplished via a speci®c DNA binding site located in the proximity of the promoter region. This allows the proteins to interact with the basal transcription machinery or perhaps blocks other proteins from doing so. We show here that SnoN binds the GTCT element. Binding to this sequence requires the participation of other cellular proteins since neither cSki nor SnoN, alone or in combination, is able to bind the GTCT sequence (Nicol and Stavnezer, 1998) ; unpublished data). Therefore we can not say with certainty whether mutations that reduce DNA binding by SnoN do so by disrupting its direct association with DNA or with the proteins required for its DNA binding. Whatever the mechanism however, we ®nd that loss of speci®c DNA binding by deletion mutants of SnoN severely impairs their transforming activity. The SnoN(D1 ± 146) mutant possesses DNA binding activity and is active in cellular transformation, although it is considerably less eective at both when compared to the full-length protein. The other mutants all fail to bind the GTCT site and are completely transformation-defective. Thus it appears that repression of genes via the GTCT element plays an important role in SnoN's transforming activity and that the identi®cation of these targets will be crucial to an understanding of the mechanism of SnoN-induced transformation.
Transcription from the tk promoter used in most of this work is activated through its Sp1 binding site (Galvin and Shi, 1997; McKnight et al., 1981) . Sp1 appears to activate transcription via its interaction with TAF II 110 (Hoey et al., 1993) . Because SnoN binds the same region of TAF II 110, it is reasonable to suggest that it represses the tk promoter by blocking Sp1's access to this factor. However, we have found that Gal4-SnoN also represses transcription from an adenovirus E1B TATA box promoter with ®ve upstream Gal4 DNA binding sites. We do not know whether this involves TAF II 110 interaction but it places SnoN among the group of DNA binding repressor proteins that contain independent repression domains that can function independently of speci®c promoter context (see review, Hanna-Rose and Hansen, 1996) . This is in contrast to the repression mechanisms of proteins such as YY (Galvin and Shi, 1997) , Mad (Ayer et al., 1993) , Id (Jen et al., 1992) , I-mf (Chen et al., 1996) and JDP2 (Aronheim et al., 1997 ) that require interactions with other upstream binding proteins or their binding sites.
Association of SnoN with TAF II 110 may quench Sp1 activation of the tk promoter but it is also possible that this interaction could mediate repression by a more active mechanism. Although no known repressors have been shown to interact with TAF II proteins, functional interactions between repressors and TBP have been demonstrated (Fondell et al., 1996; Um et al., 1995) . Thus in some systems the TFIID complex is a target of repressor function and it is reasonable to suggest that binding of TAF II 110 is involved in repression by SnoN. Because this interaction likely occurs only in association with DNA, co-immunoprecipitation assays would not be informative. We have attempted to directly study their functional interaction by co-expressing SnoN and TAF II 110 in reporter gene assays. However, we did not detect any in¯uence of TAF II 110 on repression by SnoN. The same diculty has been encountered with Sp1 despite strong evidence for its interaction with TAF II 110 (Farmer et al., 1996) . It seems likely that in vitro assays with partially reconstituted transcription systems (Sauer et al., 1995) will be required to determine whether interaction between these factors is necessary for repression by SnoN.
Materials and methods
Cell culture, transfections and soft agar cloning
The chicken embryo ®broblast cell line UMN-SAH/DF#1 (DF1) was a gift of D Foster of the University of Minnesota. All transient and stable transfections of these cells and of primary CEFs were performed using DOTAP (Boehringer Mannheim Corporation) according to the manufacturer's instructions. Cell culture and viral infection were performed as previously described (Colmenares et al., 1991) , except that DF1 cells were cultured in Dulbecco's modi®ed eagle medium with 10% fetal calf serum. For stable infection, cells were passed three to four times post transfection to allow the spread of virus. The soft agar cloning assay for transformation was done using primary CEFs as previously described (Colmenares et al., 1991) .
Reporter assays
Chloramphenicol acetyltransferase (CAT) assays were done as previously described using a reporter with a herpes simplex virus-1 thymidine kinase (tk) promoter with two double copies of the GTCTGAC element (Nicol and Stavnezer, 1998) . Chicken snoN was expressed by cloning the cDNA (Boyer et al., 1993) into the RSVPL expression vector (Nicol and Stavnezer, 1998) to generate RSVsno. For the mapping of the repression domain, regions of SnoN were fused in frame to the Gal4 DBD in the SG424 expression vector (Sadowski and Ptashne, 1989) using standard molecular biology techniques. Speci®c details of the restriction sites used are available upon request. The luciferase reporter used in these mapping studies is a derivative of pGL3-Basic plasmid (Promega) containing the tk promoter and the upstream Gal4 binding sites from pG5tkCAT (Shi et al., 1991) cloned into its NheI/BglII sites. To eliminate a putative Gal4 binding site (Liang et al., 1996) in the luciferase gene, a HindIII/BsrGI segment of pGL3 Basic was replaced with a similar fragment from pGL2 Basic (Promega) to generate the pGL3.2tk-Luc reporter. Other reporter assays were done using G5BLuc-Basic, that contains ®ve Gal4 binding sites upstream of a synthetic E1B TATA box (Lillie and Green, 1989) . This plasmid was a modi®cation of pGL3 Basic in which the promoter region of pG5BCAT (Qian et al., 1995) is inserted upstream of the luc gene at the NheI and BglII sites.
DF1 cells (1. 8610 5 ) were plated in 35 mm plates and transfected 12 ± 24 h later using a ®xed quantity of total DNA in each experiment (1.2 ± 1.5 mg). At 36 ± 48 h post transfection, lysates were prepared and assayed for luciferase activity using the Luciferase Assay System as per manufacturer's instructions (Promega). The lysates were also checked for total protein (Biorad Protein Assay) to ensure that dierences in activity are not due to variability in cell plating or lysate preparation. All reporter assays were done in duplicate, and repeated at least three times.
Western blot analysis
Western blot analysis was performed as previously described (Zheng et al., 1997) . The only dierence was the use of the SnoN speci®c monoclonal antibody (3E6).
Electrophoretic mobility shift assay (EMSA)
EMSAs were preformed as previously described (Nicol and Stavnezer, 1998) except that the quantity of nuclear extract used was increased to 20 mg of protein. The DNA-protein complexes were resolved on a 4% nondenaturing polyacrylamide gels in 0.56TBE (0.045 M Tris, 0.045 M borate, 0.001 M EDTA). Antibody supershift assays were performed as previously (Nicol and Stavnezer, 1998) with four monoclonal antibodies (mAbs): M6 and G8 anti-Ski (Colmenares et al., 1991) , 3E6 anti-Sno (this work) and EE anti-glu glu (Grussenmeyer et al., 1985) .
GST protein binding assay
The bacterial expression vector pGEX-3X (Pharmacia Biotech Inc.) was modi®ed by inserting a NcoI linker (CCCATGGG) at the SmaI site, so that the methionine codon in the linker is in frame with the upstream GST. A cDNA fragment containing SnoN (NcoI/XbaI blunted with Klenow) was inserted into the modi®ed pGEX-3X (NcoI/ EcoRI blunted with Klenow). For GST-TAF II 110, the ski cDNA was removed from the GST-cski plasmid (Heyman and Stavnezer, 1994) by cutting with NcoI/EcoRI and replaced with a fragment of the Drosophila TAF II 110 cDNA cut with the same enzymes. This allowed the expression of a chimera that fused the amino terminal 457 residues of TAF II 110 to GST.
The expression and puri®cation of GST fusion proteins as well as their use in protein binding assays were performed as previously described (Heyman and Stavnezer, 1994) . However, the amount of GST fusion protein used was 3 ± 5 mg and the quantity of the BSA in the binding buer was increased to 1 mg ml 71 .
35
S-labeled proteins were generated using the TNT system according to the manufacturer's instructions (Promega). Plasmids for expressing TAF II 60, TAF II 80, and TAF II 110 were a gift of Robert Tjian (Department of Molecular Biology, UC Berkeley) and were expressed in the pTbSTOP plasmid, a pGEM4 derivative (Promega).
S-labeled SnoN and TAF II 110 1-457 were generated from the TM1 plasmid, a gift from Dennis Templeton (Department of Pathology, Case Western Reserve University). Details on these clones are available upon request.
